Omega Healthcare Investors Financial Statements (OHI)
|
|
|
|
Report date
|
|
|
22.02.2021 |
17.02.2022 |
31.12.2022 |
14.02.2023 |
12.02.2024 |
|
31.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
892.4 |
1 063 |
878.2 |
878.2 |
949.7 |
|
1 263 |
|
Operating Income, bln rub |
|
|
452.3 |
564.9 |
78.6 |
390.3 |
761.3 |
|
332.4 |
|
EBITDA, bln rub |
? |
|
782.2 |
906.9 |
995.6 |
722.7 |
810.8 |
|
811.7 |
|
Net profit, bln rub |
? |
|
159.3 |
416.7 |
426.9 |
426.9 |
242.2 |
|
466.6 |
|
|
OCF, bln rub |
? |
|
708.3 |
722.1 |
0.000 |
625.7 |
617.7 |
|
370.9 |
|
CAPEX, bln rub |
? |
|
75.1 |
95.1 |
0.000 |
47.2 |
0.000 |
|
15.3 |
|
FCF, bln rub |
? |
|
633.1 |
627.1 |
0.000 |
578.5 |
617.7 |
|
355.5 |
|
Dividend payout, bln rub
|
|
|
612.3 |
637.6 |
0.000 |
632.9 |
643.9 |
|
339.2 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
384.3% |
153.0% |
0.00% |
148.2% |
265.9% |
|
72.7% |
|
|
OPEX, bln rub |
|
|
426.4 |
482.9 |
757.7 |
469.0 |
81.5 |
|
160.1 |
|
Cost of production, bln rub |
|
|
13.8 |
13.7 |
42.0 |
17.0 |
15.0 |
|
403.1 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
224.3 |
234.6 |
220.3 |
233.2 |
235.5 |
|
271.0 |
|
|
Assets, bln rub |
|
|
9 497 |
9 638 |
8 860 |
9 405 |
9 117 |
|
8 944 |
|
Net Assets, bln rub |
? |
|
3 842 |
3 907 |
3 609 |
3 609 |
3 575 |
|
4 208 |
|
Debt, bln rub |
|
|
5 169 |
5 254 |
19.2 |
5 287 |
5 067 |
|
4 858 |
|
Cash, bln rub |
|
|
163.5 |
20.5 |
305.6 |
297.1 |
442.8 |
|
342.4 |
|
Net debt, bln rub |
|
|
5 006 |
5 233 |
-286.4 |
4 990 |
4 625 |
|
4 516 |
|
|
Ordinary share price, rub |
|
|
36.3 |
29.6 |
28.0 |
28.0 |
30.7 |
|
33.5 |
|
Number of ordinary shares, mln |
|
|
227.7 |
236.9 |
227.7 |
236.3 |
240.5 |
|
252.7 |
|
|
Market cap, bln rub |
|
|
8 272 |
7 011 |
6 365 |
6 603 |
7 374 |
|
8 466 |
|
EV, bln rub |
? |
|
13 277 |
12 244 |
6 079 |
11 593 |
11 998 |
|
12 982 |
|
Book value, bln rub |
|
|
3 188 |
3 254 |
2 966 |
2 965 |
2 931 |
|
3 563 |
|
|
EPS, rub |
? |
|
0.70 |
1.76 |
1.87 |
1.81 |
1.01 |
|
1.85 |
|
FCF/share, rub |
|
|
2.78 |
2.65 |
0.00 |
2.45 |
2.57 |
|
1.41 |
|
BV/share, rub |
|
|
14.0 |
13.7 |
13.0 |
12.5 |
12.2 |
|
14.1 |
|
|
EBITDA margin, % |
? |
|
87.7% |
85.3% |
113.4% |
82.3% |
85.4% |
|
64.3% |
|
Net margin, % |
? |
|
17.9% |
39.2% |
48.6% |
48.6% |
25.5% |
|
36.9% |
|
FCF yield, % |
? |
|
7.65% |
8.94% |
0.00% |
8.76% |
8.38% |
|
4.20% |
|
ROE, % |
? |
|
4.15% |
10.7% |
11.8% |
11.8% |
6.78% |
|
11.1% |
|
ROA, % |
? |
|
1.68% |
4.32% |
4.82% |
4.54% |
2.66% |
|
5.22% |
|
|
P/E |
? |
|
51.9 |
16.8 |
14.9 |
15.5 |
30.4 |
|
18.1 |
|
P/FCF |
|
|
13.1 |
11.2 |
|
11.4 |
11.9 |
|
23.8 |
|
P/S |
? |
|
9.27 |
6.60 |
7.25 |
7.52 |
7.76 |
|
6.70 |
|
P/BV |
? |
|
2.59 |
2.15 |
2.15 |
2.23 |
2.52 |
|
2.38 |
|
EV/EBITDA |
? |
|
17.0 |
13.5 |
6.11 |
16.0 |
14.8 |
|
16.0 |
|
Debt/EBITDA |
|
|
6.40 |
5.77 |
-0.29 |
6.90 |
5.70 |
|
5.56 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
|
0.00% |
|
|
0 |
|
|
CAPEX/Revenue, % |
|
|
8.42% |
8.94% |
0.00% |
5.38% |
0.00% |
|
1.21% |
|
| Omega Healthcare Investors shareholders |
